161 related articles for article (PubMed ID: 33602172)
1. Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort.
Zhu D; Cao D; Shen M; Lv J
BMC Cancer; 2021 Feb; 21(1):176. PubMed ID: 33602172
[TBL] [Abstract][Full Text] [Related]
2. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
[TBL] [Abstract][Full Text] [Related]
3. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland.
Grosse A; Grosse C; Rechsteiner M; Soltermann A
Diagn Pathol; 2019 Feb; 14(1):18. PubMed ID: 30744664
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnostic characteristics based on the next generation sequencing in lung cancer and its relationship with the expression of PD-L1.
Liu J; Liu Y
Pathol Res Pract; 2020 Feb; 216(2):152797. PubMed ID: 31926773
[TBL] [Abstract][Full Text] [Related]
6. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
[TBL] [Abstract][Full Text] [Related]
7. Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion.
Wu SG; Liu YN; Yu CJ; Yang JC; Shih JY
Genes Chromosomes Cancer; 2018 Oct; 57(10):513-521. PubMed ID: 30107055
[TBL] [Abstract][Full Text] [Related]
8. Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
Bonanno L; Calabrese F; Nardo G; Calistri D; Tebaldi M; Tedaldi G; Polo V; Vuljan S; Favaretto A; Conte P; Amadori A; Rea F; Indraccolo S
Lung Cancer; 2016 Jun; 96():52-5. PubMed ID: 27133750
[TBL] [Abstract][Full Text] [Related]
9. Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.
Sun W; Feng L; Yang X; Li L; Liu Y; Lv N; Lin D
Hum Pathol; 2018 Nov; 81():261-271. PubMed ID: 30420048
[TBL] [Abstract][Full Text] [Related]
10. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
Wen S; Dai L; Wang L; Wang W; Wu D; Wang K; He Z; Wang A; Chen H; Zhang P; Dong X; Dong YA; Wang K; Yao M; Wang M
Oncologist; 2019 Nov; 24(11):e1070-e1081. PubMed ID: 30902917
[TBL] [Abstract][Full Text] [Related]
11. Analysis of multigene detection in patients with advanced lung adenocarcinoma using cytological specimens.
Ma Y; Du Y; Wang R; Ji X; Wu J; Liu Y; Guo X; Zhang Y
Pathol Res Pract; 2020 Aug; 216(8):153036. PubMed ID: 32703499
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study.
Song Y; Jia Z; Wu P; Wang W; Ou Q; Bao H; Yu M; Wu X; Liu P; Liang N; Zhang S; Li S
BMC Pulm Med; 2020 Apr; 20(1):80. PubMed ID: 32245453
[TBL] [Abstract][Full Text] [Related]
13. Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions.
Li W; Qiu T; Ling Y; Gao S; Ying J
Mol Oncol; 2018 May; 12(5):677-689. PubMed ID: 29518290
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment is an effective approach for patients with synchronous multiple primary lung cancers.
Peng Y; Ren W; Wang H; Li M; Feng Z; Peng Z
J Cancer Res Ther; 2017; 13(4):702-706. PubMed ID: 28901318
[TBL] [Abstract][Full Text] [Related]
15. Synchronous Pulmonary Adenocarcinomas.
Pagan CA; Shu CA; Crapanzano JP; Lagos GG; Stoopler MB; Rizvi NA; Heymann JJ; Sonett JR; Fernandes H; Saqi A
Am J Clin Pathol; 2020 Jun; 154(1):57-69. PubMed ID: 32146481
[TBL] [Abstract][Full Text] [Related]
16. Genetic Alterations in Preinvasive Lung Synchronous Lesions.
Ahn S; Lim J; Park SY; Kim H; Kwon HJ; Han YB; Lee CT; Cho S; Chung JH
Cancer Res Treat; 2020 Oct; 52(4):1120-1134. PubMed ID: 32599981
[TBL] [Abstract][Full Text] [Related]
17. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
[TBL] [Abstract][Full Text] [Related]
18. Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report.
Yang Y; Xie X; Jiang G; Liu H
J Cardiothorac Surg; 2020 Jul; 15(1):196. PubMed ID: 32727606
[TBL] [Abstract][Full Text] [Related]
19. High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules.
Wu C; Zhao C; Yang Y; He Y; Hou L; Li X; Gao G; Shi J; Ren S; Chu H; Zhou C; Zhang J; Schmid-Bindert G
J Thorac Oncol; 2015 May; 10(5):778-783. PubMed ID: 25629635
[TBL] [Abstract][Full Text] [Related]
20. Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study.
Serizawa M; Koh Y; Kenmotsu H; Isaka M; Murakami H; Akamatsu H; Mori K; Abe M; Hayashi I; Taira T; Maniwa T; Takahashi T; Endo M; Nakajima T; Ohde Y; Yamamoto N
Cancer; 2014 May; 120(10):1471-81. PubMed ID: 24700479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
